Profile
| Role | Director |
|---|---|
| Notability | 20/100 |
Board memberships
- Illumina, Inc.
- Fate Therapeutics Inc
- Veracyte, Inc.
Updated Jul 16, 2026
EPSTEIN ROBERT S has filed 4 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $1.77M.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-15 | VCYT | VERACYTE, INC. | A — Grant or award | 5.3K | $0.00 | |
| 2026-05-22 | VCYT | VERACYTE, INC. | S — Open-market sale | 10.0K | $44.01 | $440K |
| 2026-05-06 | FATE | FATE THERAPEUTICS INC | M — Option exercise | 25.0K | $1.69 | $42K |
| 2025-10-01 | VCYT | VERACYTE, INC. | S — Open-market sale | 21.5K | $35.08 | $753K |
| 2025-10-01 | VCYT | VERACYTE, INC. | M — Option exercise | 10.0K | $7.94 | $79K |
| 2025-06-18 | VCYT | VERACYTE, INC. | A — Grant or award | 9.3K | $0.00 | |
| 2025-05-21 | ILMN | ILLUMINA, INC. | A — Grant or award | 3.8K | $0.00 | |
| 2024-11-14 | VCYT | VERACYTE, INC. | S — Open-market sale [10b5-1] | 15.0K | $38.32 | $575K |
| 2024-11-14 | VCYT | VERACYTE, INC. | M — Option exercise [10b5-1] | 15.0K | $8.04 | $121K |
EPSTEIN ROBERT S is a corporate insider — currently tracked as Director of VERACYTE, INC. (VCYT). InsiderAlpha tracks every SEC Form 4 filing in real time.
4 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($1.77M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live EPSTEIN ROBERT S profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.